CEMIG (NYSE: CIG)

$1.93-1.03%today

Brazilian ADR trading on the NYSE, priced in US dollars.

Display currency

Market Cap, EPS and the financial totals below — switch between US dollars and BRL.

Market Cap: —
P/E (TTM): 5.8x
P/B: 1.0x
EPS (TTM): $0.33
Dividend Yield: 9.17%
52-Week Range: $1.88 – $2.76
Volume: 5.05M
Previous Close: $1.95

TTM = trailing twelve months — the most recent 12 months (a rolling window), used for P/E, EPS and dividends. On the tables and charts below, the in-progress current year appears as a “Last 12M” column labelled with the quarter range it covers.

Performance

Today

-1.03%

1 Week

-5.39%

1 Month

-9.81%

YTD

-3.50%

1 Year

-1.03%

5 Years

+16.16%

About CEMIG

US Ticker: CIG
B3 Ticker: CMIG4
Exchange: NYSE
Currency: USD
Sector: Utilities
Industry: Utilities - Regulated Electric
Headquarters: Belo Horizonte, MG, Brazil
Employees: 5,320
CEO: Mr. Alexandre Ramos Peixoto
Founded: 1952

Companhia Energética de Minas Gerais - CEMIG, through its subsidiaries, engages in the generation, transmission, distribution, and sale of energy in Brazil.

As of December 31, 2025, the company operated 32 hydro plants with a total capacity of 4,434 M, 2 wind farms with a total capacity of 71 MW, and 12 photovoltaic power stations with a total capacity of 169 MW; 365,577 miles of distribution lines; and 4,865 miles of transmission lines.

It is also involved in the acquisition, transportation, and distribution of gas and its sub products and derivatives; sale and trading of energy; construction, implementation, operation and maintenance of electricity transmission; marketing and intermediation of energy-related business; installation, operation, maintenance and rental of solar plants; and distributed generation, account services, cogeneration, energy efficiency, and supply and storage management activities.

The company was incorporated in 1952 and is headquartered in Belo Horizonte, Brazil.

www.cemig.com.br

Analyst Ratings

Consensus of 3 Wall Street analysts · sourced from Yahoo Finance

None

On a 1–5 scale: 1 = Strong Buy, 3 = Hold, 5 = Sell. Lower is more bullish.

12-Month Price Target

Low

$1.91

Average

$2.14

High

$2.50

The average target is +10.71% above the current price of $1.93.

Financial Results

Revenue, EBITDA and net profit (in USD) with net margin (net profit ÷ revenue).

Financial Health

Margins, leverage and cash-flow quality derived from CEMIG's income statement, balance sheet and cash flow (absolute figures in USD).

ProfitabilityLeverageGrowth

Overall: Financially Solid

Net Margin: 11.2%
ROE: 17.1%
Rev Growth (YoY): +1.86%
Net Debt / EBITDA: 2.71×
Current Ratio: 0.93×
Interest Coverage: 3.95×
Free Cash Flow: 628.9M
Payout Ratio: 95.8%

Income — Margins & Efficiency

Metric	Last 12MQ2'25 – Q1'26	Δ	2025	Δ	2024	Δ	2023	Δ	2022	Δ	2021	Δ	2020	Δ	2019	Δ	2018	Δ	2017	Δ	2016	Δ	2015	Δ	2014	Δ	2013	Δ	2012	Δ	2011	Δ	2010	Δ	2009	Δ	2008	Δ	2007	Δ	2006
Revenue	$8,385,548,612	+7.4%	$7,806,690,771	+21.1%	$6,445,555,933	-15.2%	$7,597,624,840	+16.5%	$6,521,401,809	+8.0%	$6,040,357,617	+24.3%	$4,860,100,650	-23.4%	$6,346,572,251	+10.3%	$5,755,768,933	-12.2%	$6,557,337,441	+13.6%	$5,772,222,735	+4.4%	$5,526,827,912	-25.1%	$7,382,916,996	+19.1%	$6,199,720,256	-10.3%	$6,912,620,410	+4.0%	$6,644,327,686	-19.9%	$8,297,232,250	+19.0%	$6,975,329,891	+18.6%	$5,882,960,413	+10.3%	$5,335,823,007	+180.9%	$1,899,577,663
Gross profit	$1,090,239,034	-17.5%	$1,321,536,832	+4.3%	$1,267,420,968	-26.7%	$1,728,588,512	+34.1%	$1,289,028,498	+6.8%	$1,206,958,458	+16.4%	$1,037,019,256	-29.3%	$1,466,240,972	+22.9%	$1,193,020,495	-6.5%	$1,275,708,979	-4.5%	$1,335,362,666	-13.2%	$1,537,897,743	-39.9%	$2,559,436,344	+26.4%	$2,025,600,814	-6.7%	$2,172,020,928	-7.6%	$2,351,490,457	-18.4%	$2,882,069,795	+5.5%	$2,732,644,865	-29.2%	$3,860,585,198	+3.8%	$3,718,101,058	+95.7%	$1,899,577,663
Operating income	$881,282,261	-23.7%	$1,155,545,816	-4.7%	$1,212,709,820	-5.3%	$1,280,978,104	+19.1%	$1,075,956,553	-13.8%	$1,247,890,560	+37.6%	$906,597,180	+20.9%	$750,053,975	+0.9%	$743,121,160	-6.9%	$797,922,141	+43.9%	$554,684,377	-53.3%	$1,188,616,777	-44.0%	$2,124,260,578	+14.9%	$1,849,277,328	+8.8%	$1,699,183,414	-1.7%	$1,727,964,830	-19.3%	$2,141,395,909	+13.0%	$1,895,008,606	+92.6%	$984,079,174	-16.3%	$1,176,370,735	+592.5%	$169,873,299
EBITDA	$1,308,590,408	-17.7%	$1,589,788,539	-16.4%	$1,900,645,851	+0.7%	$1,886,932,498	+59.9%	$1,180,221,776	-4.9%	$1,241,427,597	+4.0%	$1,193,833,983	-30.0%	$1,705,551,022	+56.6%	$1,088,999,019	-11.9%	$1,236,447,102	+24.4%	$993,758,263	-31.2%	$1,443,627,265	-39.3%	$2,377,453,751	-1.1%	$2,403,679,057	-27.4%	$3,310,840,546	+24.4%	$2,660,840,661	-10.1%	$2,960,288,809	-5.4%	$3,129,087,780	+86.4%	$1,678,571,429	-22.4%	$2,164,318,452	-16.9%	$2,603,472,548
Net profit	$937,109,226	+4.8%	$894,233,227	-22.4%	$1,152,009,583	-3.1%	$1,188,404,602	+53.5%	$774,325,398	+15.0%	$673,404,905	+22.1%	$551,741,250	-30.6%	$795,375,962	+78.9%	$444,478,860	+47.0%	$302,316,451	+194.4%	$102,696,553	-83.5%	$624,004,853	-47.2%	$1,181,944,915	-10.2%	$1,315,644,471	-37.0%	$2,088,895,409	+61.3%	$1,294,767,317	-4.7%	$1,358,604,091	+11.0%	$1,223,752,151	+62.2%	$754,302,926	-17.6%	$915,520,851	+493.0%	$154,387,611
Gross margin	13.0%	-3.9 p.p.	16.9%	-2.7 p.p.	19.7%	-3.1 p.p.	22.8%	+3.0 p.p.	19.8%	-0.2 p.p.	20.0%	-1.4 p.p.	21.3%	-1.8 p.p.	23.1%	+2.4 p.p.	20.7%	+1.3 p.p.	19.5%	-3.7 p.p.	23.1%	-4.7 p.p.	27.8%	-6.8 p.p.	34.7%	+2.0 p.p.	32.7%	+1.3 p.p.	31.4%	-4.0 p.p.	35.4%	+0.7 p.p.	34.7%	-4.4 p.p.	39.2%	-26.4 p.p.	65.6%	-4.1 p.p.	69.7%	-30.3 p.p.	100.0%
Operating margin	10.5%	-4.3 p.p.	14.8%	-4.0 p.p.	18.8%	+2.0 p.p.	16.9%	+0.4 p.p.	16.5%	-4.2 p.p.	20.7%	+2.0 p.p.	18.7%	+6.8 p.p.	11.8%	-1.1 p.p.	12.9%	+0.7 p.p.	12.2%	+2.6 p.p.	9.6%	-11.9 p.p.	21.5%	-7.3 p.p.	28.8%	-1.1 p.p.	29.8%	+5.2 p.p.	24.6%	-1.4 p.p.	26.0%	+0.2 p.p.	25.8%	-1.4 p.p.	27.2%	+10.4 p.p.	16.7%	-5.3 p.p.	22.0%	+13.1 p.p.	8.9%
EBITDA margin	15.6%	-4.8 p.p.	20.4%	-9.1 p.p.	29.5%	+4.7 p.p.	24.8%	+6.7 p.p.	18.1%	-2.5 p.p.	20.6%	-4.0 p.p.	24.6%	-2.3 p.p.	26.9%	+8.0 p.p.	18.9%	+0.1 p.p.	18.9%	+1.6 p.p.	17.2%	-8.9 p.p.	26.1%	-6.1 p.p.	32.2%	-6.6 p.p.	38.8%	-9.1 p.p.	47.9%	+7.8 p.p.	40.0%	+4.4 p.p.	35.7%	-9.2 p.p.	44.9%	+16.3 p.p.	28.5%	-12.0 p.p.	40.6%	-96.5 p.p.	137.1%
Net margin	11.2%	-0.3 p.p.	11.5%	-6.4 p.p.	17.9%	+2.2 p.p.	15.6%	+3.8 p.p.	11.9%	+0.7 p.p.	11.1%	-0.2 p.p.	11.4%	-1.2 p.p.	12.5%	+4.8 p.p.	7.7%	+3.1 p.p.	4.6%	+2.8 p.p.	1.8%	-9.5 p.p.	11.3%	-4.7 p.p.	16.0%	-5.2 p.p.	21.2%	-9.0 p.p.	30.2%	+10.7 p.p.	19.5%	+3.1 p.p.	16.4%	-1.2 p.p.	17.5%	+4.7 p.p.	12.8%	-4.3 p.p.	17.2%	+9.0 p.p.	8.1%
Revenue growth (YoY)	1.9%	-5.5 p.p.	7.4%	-0.7 p.p.	8.1%	+1.1 p.p.	6.9%	+4.5 p.p.	2.4%	-30.9 p.p.	33.4%	+34.4 p.p.	-1.0%	-15.3 p.p.	14.3%	+11.6 p.p.	2.7%	-13.0 p.p.	15.7%	+29.8 p.p.	-14.2%	-25.8 p.p.	11.6%	-22.4 p.p.	34.0%	+30.5 p.p.	3.5%	-10.6 p.p.	14.1%	+24.2 p.p.	-10.1%	-23.6 p.p.	13.4%	+24.5 p.p.	-11.1%	-56.1 p.p.	45.0%	-88.0 p.p.	133.0%	—	—
Effective tax rate	12.1%	-1.5 p.p.	13.6%	-10.3 p.p.	23.9%	+8.1 p.p.	15.8%	+15.2 p.p.	0.6%	-19.5 p.p.	20.1%	-4.5 p.p.	24.6%	-10.4 p.p.	35.0%	+4.7 p.p.	30.3%	-8.8 p.p.	39.1%	+30.1 p.p.	9.0%	-17.6 p.p.	26.6%	-3.4 p.p.	30.0%	+6.5 p.p.	23.4%	+7.1 p.p.	16.3%	-7.4 p.p.	23.7%	+4.1 p.p.	19.5%	-14.4 p.p.	33.9%	+3.8 p.p.	30.1%	+0.4 p.p.	29.7%	+71.2 p.p.	-41.5%
Interest coverage	3.95×	-17.2%	4.77×	-90.6%	50.62×	+53.2%	33.03×	+28.6%	25.69×	+1.8%	25.24×	+18.8%	21.24×	+23.3%	17.22×	+594.2%	2.48×	+22.2%	2.03×	+71.9%	1.18×	-63.3%	3.22×	-39.8%	5.35×	-12.5%	6.11×	-8.0%	6.65×	+61.2%	4.12×	+24.8%	3.30×	-13.3%	3.81×	-24.1%	5.02×	+9.7%	4.58×	+568.7%	0.68×

Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.

Balance Sheet — Health & Leverage

Metric	Last 12MQ2'25 – Q1'26	Δ	2025	Δ	2024	Δ	2023	Δ	2022	Δ	2021	Δ	2020	Δ	2019	Δ	2018	Δ	2017	Δ	2016	Δ	2015	Δ	2014	Δ	2013	Δ	2012	Δ	2011	Δ	2010	Δ	2009	Δ	2008	Δ	2007	Δ	2006
Net debt	$3,544,380,874	+8.0%	$3,281,819,510	+87.5%	$1,749,947,393	-2.7%	$1,799,307,245	+0.2%	$1,796,199,523	-7.2%	$1,935,885,067	-25.9%	$2,613,642,997	-27.8%	$3,618,039,246	+1.0%	$3,583,000,878	-11.3%	$4,037,373,078	-16.5%	$4,832,997,263	+34.3%	$3,599,509,187	-24.3%	$4,755,661,053	+54.7%	$3,075,064,638	-32.1%	$4,531,729,989	-34.6%	$6,925,798,842	+12.3%	$6,164,861,613	+56.5%	$3,940,332,760	+101.6%	$1,954,388,985	-31.3%	$2,846,149,494	+12.0%	$2,541,529,798
Net Debt / Equity	0.65×	+2.5%	0.63×	+59.3%	0.39×	+11.5%	0.35×	-18.8%	0.44×	-21.4%	0.55×	-28.6%	0.78×	-14.0%	0.90×	+3.6%	0.87×	-6.6%	0.93×	-22.9%	1.21×	+10.4%	1.10×	-2.1%	1.12×	+94.9%	0.57×	-28.5%	0.80×	-27.0%	1.10×	+23.2%	0.89×	+45.1%	0.62×	+26.4%	0.49×	-20.4%	0.61×	-5.5%	0.65×
Net Debt / EBITDA	2.71×	+31.2%	2.06×	+124.2%	0.92×	-3.4%	0.95×	-37.3%	1.52×	-2.4%	1.56×	-28.8%	2.19×	+3.2%	2.12×	-35.5%	3.29×	+0.8%	3.27×	-32.9%	4.86×	+95.1%	2.49×	+24.6%	2.00×	+56.4%	1.28×	-6.5%	1.37×	-47.4%	2.60×	+25.0%	2.08×	+65.4%	1.26×	+8.2%	1.16×	-11.5%	1.32×	+34.7%	0.98×
Debt / Equity	0.69×	-0.4%	0.70×	+49.9%	0.46×	+11.5%	0.42×	-17.0%	0.50×	-15.9%	0.60×	-31.6%	0.87×	-6.8%	0.94×	+1.0%	0.93×	-7.8%	1.00×	-21.5%	1.28×	+9.7%	1.17×	-2.6%	1.20×	+60.0%	0.75×	-22.7%	0.97×	-27.9%	1.34×	+16.6%	1.15×	+13.9%	1.01×	+45.0%	0.70×	-15.8%	0.83×	+6.3%	0.78×
Current ratio	0.93×	-7.0%	1.00×	+15.8%	0.86×	-4.6%	0.91×	-24.6%	1.20×	-0.8%	1.21×	-24.0%	1.60×	+22.7%	1.30×	+9.4%	1.19×	+20.6%	0.99×	+37.5%	0.72×	+0.0%	0.72×	+10.7%	0.65×	-42.5%	1.13×	+63.7%	0.69×	-1.9%	0.70×	-44.5%	1.26×	+50.6%	0.84×	-34.1%	1.27×	-3.3%	1.32×	+19.2%	1.10×
Return on equity (ROE)	17.1%	-0.1 p.p.	17.1%	-8.9 p.p.	26.0%	+2.6 p.p.	23.4%	+4.6 p.p.	18.8%	-0.5 p.p.	19.3%	+2.9 p.p.	16.4%	-3.4 p.p.	19.8%	+9.0 p.p.	10.8%	+3.8 p.p.	7.0%	+4.4 p.p.	2.6%	-16.4 p.p.	19.0%	-8.8 p.p.	27.8%	+3.2 p.p.	24.6%	-12.4 p.p.	37.0%	+16.4 p.p.	20.6%	+0.9 p.p.	19.7%	+0.6 p.p.	19.1%	+0.3 p.p.	18.8%	-0.9 p.p.	19.7%	+15.7 p.p.	3.9%
Return on assets (ROA)	7.2%	-0.1 p.p.	7.3%	-4.6 p.p.	11.9%	+1.4 p.p.	10.5%	+2.9 p.p.	7.6%	+0.4 p.p.	7.2%	+1.9 p.p.	5.3%	-1.0 p.p.	6.3%	+3.4 p.p.	2.9%	+0.5 p.p.	2.4%	+1.6 p.p.	0.8%	-5.2 p.p.	6.0%	-2.9 p.p.	9.0%	-1.4 p.p.	10.4%	-2.7 p.p.	13.1%	+6.6 p.p.	6.5%	-0.2 p.p.	6.7%	-0.3 p.p.	7.0%	-0.0 p.p.	7.1%	+0.4 p.p.	6.6%	+5.2 p.p.	1.4%
Book value / share	$1.92	+5.4%	$1.82	+17.7%	$1.55	-12.8%	$1.78	-5.2%	$1.87	+18.0%	$1.59	+35.1%	$1.18	-16.1%	$1.40	-25.0%	$1.87	-4.9%	$1.97	-3.9%	$2.05	+21.7%	$1.68	-2.3%	$1.72	-39.0%	$2.82	+23.3%	$2.29	-10.3%	$2.55	-15.8%	$3.03	+16.8%	$2.59	+60.3%	$1.62	-12.4%	$1.85	+18.7%	$1.56

Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.

Net Debt & Leverage

Free Cash Flow

Margins

Dividend Payout Ratio

Capex ÷ Revenue

Cash Conversion (operating cash flow ÷ net income)

Ratios computed from company financial statements. Net Debt = total debt − cash & equivalents; FCF = operating cash flow − capital expenditure; absolute values in USD.

Valuation & Dividends

P/E Ratio History

Dividend History

This year (YTD) $0.13/share · yield 6.94%

Dividends and yield from Yahoo Finance (per ADR share, in US dollars). The current-year figures are calendar year-to-date (dividends actually paid this year), not the trailing 12 months.

Listings

CEMIG trades on 6 exchanges. Prices on this page are the NYSE ADR (CIG).

Exchange	Ticker	Currency
NYSEpriced here	CIG	USD
B3 (São Paulo)	CMIG4	BRL
Latibex (Madrid)	XCM	EUR
Frankfurt	CIDA	EUR
Mexico (BMV)	CIG	MXN
Buenos Aires (BYMA)	CIG	ARS

Frequently Asked Questions

Why hold CEMIG CIG ADR instead of local B3 CMIG4 shares?

Buying directly on Brazil’s B3 exchange means opening a local brokerage account, converting currency and dealing with Brazilian tax paperwork. ADRs remove that friction: they settle in dollars, follow US market hours, and report in formats foreign investors already understand.

The trade-off is that an ADR’s price reflects two moving parts: (1) the underlying share price, quoted in reais on the B3, and (2) the USD/BRL exchange rate. Because of that second part, a rising company can still deliver a flat, or even negative, dollar return if the real weakens against the dollar. The same applies to ETFs: funds such as EWZ, EWZS and FLBR bundle dozens of these companies into a single ticker for instant diversification, but their dollar value still moves with the real.

Where is CEMIG listed?

CEMIG trades on 6 exchanges. The line quoted on this page is NYSE in the United States (CIG, US dollars). It also trades on B3 (São Paulo) in Brazil (CMIG4, Brazilian reais), Latibex (Madrid) in Spain (XCM, euros), Frankfurt in Germany (CIDA, euros), Mexico (BMV) in Mexico (CIG, Mexican pesos) and Buenos Aires (BYMA) in Argentina (CIG, Argentine pesos).

On how many exchanges does CEMIG trade?

6. NYSE — CIG (USD) · B3 (São Paulo) — CMIG4 (BRL) · Latibex (Madrid) — XCM (EUR) · Frankfurt — CIDA (EUR) · Mexico (BMV) — CIG (MXN) · Buenos Aires (BYMA) — CIG (ARS). Prices shown on this page are the NYSE line, CIG.

What is CEMIG's primary listing?

CEMIG's primary listing is on the B3 in Brazil, where the shares trade as CMIG4 in reais — the company's home market. The NYSE line quoted on this page is an ADR over those same shares: it gives you the asset in US dollars, on US market hours, without opening a Brazilian brokerage account or trading in reais.

What is the difference between CIG and CMIG4?

They are the same company and, economically, the same asset. CMIG4 is the original Brazilian share, listed on the B3 and quoted in reais. CIG is an American Depositary Receipt over that share, listed on the NYSE and quoted in US dollars — a wrapper whose purpose is to give foreign investors access to the Brazilian asset without opening an account in Brazil. The CIG price therefore tracks two things: CMIG4 in reais, and the USD/BRL exchange rate.

How can I buy CEMIG stock in Europe?

CEMIG trades in euros on 2 European venues: Latibex (Madrid) in Spain (XCM) and Frankfurt in Germany (CIDA). A European broker with access to any of them can buy it in EUR, with no currency conversion on your side. The price shown on this page is the NYSE line (CIG), quoted in US dollars.

How can I buy CEMIG stock in the United States?

CEMIG is listed on the NYSE under CIG, priced in US dollars. Any US brokerage offering NYSE-listed securities can trade it, with no foreign-account paperwork and no currency conversion.

As of Fri, Aug 14, 17:00 BRT · Market closed

Financial data last updated: August 15, 2026

← All stocks & ETFs